Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY:BDX)

202.47 -7.56 (-3.60%)
Streaming Delayed Price Updated: 11:58 AM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
Becton, Dickinson's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 20 Years Ago Would Be Worth $6,900 Today ↗
 
Via Benzinga
News headline image
Where Becton, Dickinson Stands With Analysts ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023 ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In Becton, Dickinson 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Becton, Dickinson ↗
 
Via Benzinga
News headline image
Becton, Dickinson's Debt Overview ↗
 
Via Benzinga
News headline image
(BDX) - Analyzing Becton, Dickinson's Short Interest ↗
 
Via Benzinga
News headline image
Becton, Dickinson Shares Dip Despite Q2 Earnings Beat - Here's The Deatils ↗
Becton, Dickinson, and Company (NYSE: BDX) posted profits of $460 million, equivalent to $2.86 per share,  
Via Benzinga
News headline image
Becton Dickinson 'Capable Of Sustaining A Breakout', Analyst Upgrades Stock With 20% Upside Potential ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023 ↗
 
Via Benzinga
News headline image
Looking Into Becton's Return On Capital Employed ↗
 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Becton, Dickinson ↗
 
Via Benzinga
A Bullish Sign Appears On Becton, Dickinson's Chart ↗
 
Via Benzinga
News headline image
Dividend Income Update March 2023 ↗
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
News headline image
7 Dividend Aristocrats to Buy for Consistent Income Growth ↗
The dividend aristocrats each provide consistent income growth over the long-term that those seeking passive income can rely on. 
Via InvestorPlace
News headline image
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential ↗
These three spinoffs are already profitable. 
Via The Motley Fool
News headline image
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield. 
Via MarketBeat
News headline image
3 Stocks To Buy For Consistent Dividend Growth ↗
One way to avoid some of the volatility in the stock market is to buy old companies that have a long history of raising dividends. These are companies with iconic brands, lasting products, and... 
Via Talk Markets
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
By David Willey, Benzinga 
Via TheNewswire.com
News headline image
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? 
Via News Direct
News headline image
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? ↗
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. 
Via Benzinga
News headline image
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its 
Via MarketBeat
Topics Initial Public Offering
News headline image
The 7 Best Dividend Growth Stocks for Long-Term Investors ↗
Although passive income is always useful under uncertain times, why not get capital gains through the best dividend growth stocks? 
Via InvestorPlace
News headline image
Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software ↗
Becton Dickinson and Co (NYSE: BDX) issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software. 
Via Benzinga
News headline image
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO ↗
Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in... 
Via Benzinga
News headline image
Why Embecta Stock Popped by Nearly 13% Today ↗
Twin beats and raised guidance make for a good day on the market for the diabetes care specialist. 
Via The Motley Fool
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
By David Willey, Benzinga 
Via TheNewswire.com
Topics Economy
News headline image
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products 
Via News Direct
Topics Economy
News headline image
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products ↗
Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.